PeptiDream Inc. | Balance Sheet

Fiscal year is July-June. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,600
5,880
6,909
6,557
3,505
Total Accounts Receivable
182
347
1,401
1,755
3,094
Inventories
-
-
-
-
166
Other Current Assets
52
137
289
210
1,434
Total Current Assets
5,835
6,364
8,599
8,521
8,199
Net Property, Plant & Equipment
165
1,362
3,139
4,856
6,143
Total Investments and Advances
-
-
-
-
1,900
Long-Term Note Receivable
-
-
100
100
100
Intangible Assets
-
3
106
122
117
Other Assets
-
8
12
29
34
Total Assets
5,999
7,738
11,956
13,628
16,502
Accounts Payable
9
16
10
24
36
Income Tax Payable
26
509
729
265
617
Other Current Liabilities
101
301
959
1,059
1,060
Total Current Liabilities
136
826
1,698
1,348
1,713
Provision for Risks & Charges
-
-
16
100
80
Deferred Taxes
-
1
1
1
10
Total Liabilities
136
826
1,714
1,448
1,794
Common Equity (Total)
5,863
6,912
10,243
12,181
14,709
Total Shareholders' Equity
5,863
6,912
10,243
12,181
14,709
Total Equity
5,863
6,912
10,243
12,181
14,709
Liabilities & Shareholders' Equity
5,999
7,738
11,956
13,628
16,502

About PeptiDream

View Profile
Address
3-25-23 Tonomachi
Kawasaki Kanagawa 210
Japan
Employees -
Website http://www.peptidream.com
Updated 07/08/2019
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.